Trials / Sponsors / Neurogene Inc.
Neurogene Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome Rett Syndrome | Phase 3 | 2023-06-13 |
| Active Not Recruiting | Gene Therapy Study for Children With CLN5 Batten Disease Neuronal Ceroid Lipofuscinosis CLN5 | Phase 1 / Phase 2 | 2022-01-31 |
| Completed | NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer Solid Tumor, Advanced Solid Tumor | Phase 1 | 2021-04-26 |
| Terminated | A Natural History Study of Charcot-Marie-Tooth 4J (CMT4J) Charcot-Marie-Tooth Disease, Hereditary Motor and Sensory Neuropathy IV | — | 2019-07-18 |
| Terminated | A Natural History Study of Aspartylglucosaminuria Aspartylglucosaminuria, Aspartylglucosamidase (AGA) Deficiency, Lysosomal Storage Diseases | — | 2019-04-18 |
| Completed | A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5) Ceroid Lipofuscinosis, Neuronal 5 | — | 2019-03-13 |